Can we predict who benefits from heart failure device therapy?
NCT ID NCT06977217
First seen Jun 16, 2026 · Last updated Jun 23, 2026 · Updated 2 times
Summary
This study enrolls 270 heart failure patients without a specific heart electrical pattern (non-LBBB) who are getting a cardiac resynchronization therapy defibrillator (CRT-D). Researchers want to find out which factors predict a good response to the device, measured by heart function improvement after 12 months. The goal is to better identify patients who will benefit most from this therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cardiac resynchronization therapy with a defibrillator (CRT-D)
What this could lead to
If successful, this study could help doctors predict which heart failure patients without a specific ECG pattern will benefit most from CRT-D, improving treatment decisions.
What could go wrong
This is an observational study, not a treatment trial. It aims to find predictors, not test a new therapy. Results may not apply to all patients or change current practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.